HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Balakrishna S Hosmane Selected Research

Edema (Dropsy)

4/2002Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Balakrishna S Hosmane Research Topics

Disease

2Headache (Headaches)
06/2012 - 04/2002
2Pain (Aches)
06/2012 - 04/2002
1Diabetic Neuropathies (Diabetic Neuropathy)
06/2012
1Dizziness (Lightheadedness)
06/2012
1Nausea
06/2012
1Neuralgia (Stump Neuralgia)
06/2012
1Vomiting
06/2012
1Neoplasms (Cancer)
04/2002
1Weight Gain
04/2002
1Asthenia
04/2002
1Edema (Dropsy)
04/2002
1Adenocarcinoma
04/2002
1Rhinitis
04/2002

Drug/Important Bio-Agent (IBA)

15-(2-azetidinylmethoxy)-2-chloropyridineIBA
06/2012
1LigandsIBA
06/2012
1Morphine (MS Contin)FDA LinkGeneric
06/2012
1NicotineFDA Link
06/2012
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
06/2012
1Endothelin Receptor AntagonistsIBA
04/2002
1Prostate-Specific Antigen (Semenogelase)IBA
04/2002
1AtrasentanIBA
04/2002
1Endothelin Receptors (Endothelin Receptor)IBA
04/2002
1Pharmaceutical PreparationsIBA
04/2002

Therapy/Procedure

1Hemodilution
04/2002
1Therapeutics
04/2002